Loading
A phase 2 trial in pancreatic cancer, run by Minia University, now recruiting.
Reinforced Pancreaticojejunostomy With or Without glubran2 is a phase 2, randomised interventional study registered as NCT06756074 by Minia University, with a registry enrolment figure of 100 participants, started 2025-01-15 and due to reach its primary completion in 2026-04-15. Interventions recorded: Reinforced pancreaticojejunostomy with tissue adhesive glue modified cyanoacrylate (glubran 2); Pancreaticojejunostomy without tissue adhesive glue modified cyanoacrylate (glubran 2). Conditions listed: Pancreatic Fistula; Pancreas Cancer; Periampullary Carcinoma; Pancreatic Ductal Adenocarcinoma. Primary outcome: the rate of Postoperative pancreatic fistula within 2 weeks after operation. Pancreatic eligibility wording from the registry: "* All the patients undergoing pancreaticoduodenectomy for cancer". Sites: Egypt. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/